Safety of PD-1/PD-L1 Inhibitors Combined With Palliative Radiotherapy and Anti-Angiogenic Therapy in Advanced Hepatocellular Carcinoma

Safety of PD-1/PD-L1 Inhibitors Combined With Palliative Radiotherapy and Anti-Angiogenic Therapy in Advanced Hepatocellular Carcinoma

BackgroundPrevious studies have explored cancer immunotherapy with radiotherapy or anti-angiogenic therapy, but no trials have reported a triple therapy approach. This study aimed to investigate safety and clinical outcome of PD-1/PD-L1 inhibitors combined with palliative radiotherapy and targeted a...

Full description

Bibliographic Details
Main Authors: Liting Zhong, Dehua Wu, Weiwei Peng, Hailong Sheng, Yazhi Xiao, Xuebing Zhang, Yuli Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
immunotherapy
immune checkpoint inhibitor
radiotherapy
anti-angiogenic therapy
targeted angiogenesis therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.686621/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.686621/full

Similar Items